Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9486e22cb0f344a140217363141cf12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87b691be40e26aa5314a708f063dce8d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0fee919b25f67af4712af4db7b3381f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
filingDate |
2011-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a5085253c08726bc9dc2a6201bf6955 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d226a38f0f220bf31dc4b59a3abed9c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d8e7ec4aaf17cc6b7faf20366519d17 |
publicationDate |
2012-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2012058128-A2 |
titleOfInvention |
Caprolactam mglur5 receptor modulators |
abstract |
The present invention is directed to caprolactams which are positive allosteric modulators of metabotropic glutamate receptors, particularly the mGluR5 receptor, and which are useful in the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which metabotropic glutamate receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which metabotropic glutamate receptors are involved. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8772301-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10077243-B2 |
priorityDate |
2010-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |